Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
844
datasets available to search
ShareScore release 0.9.0
Dataset results
844 results for “cross-section”
Factors associated with attitudes toward HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil
Open the record for dataset details and reuse information.
Nasopharyngeal swabs vs. saliva sampling for SARS-CoV-2 detection: A cross-sectional survey of acceptability for caregivers and children after experiencing both methods
Open the record for dataset details and reuse information.
Government management capacities and the containment of COVID-19: A repeated cross-sectional study across Chinese cities
Open the record for dataset details and reuse information.
Data from: Long-term benefit of hepatitis C therapy in a safety net hospital system: a cross-sectional study with median 5-year follow-up
Open the record for dataset details and reuse information.
Prevalence, severity, and risk factors of disability among adults living with HIV accessing routine outpatient HIV care in London, United Kingdom (UK): A cross-sectional self-report study
Open the record for dataset details and reuse information.
Data from: Cross-sectional versus longitudinal research: a case study of trees with hollows and marsupials in Australian forests
Open the record for dataset details and reuse information.
Impact of smoking cessation, coffee and bread consumption on the intestinal microbial composition among Saudis: A cross-sectional study
Open the record for dataset details and reuse information.
Clinical Trial Transparency and Data-Sharing Among Bio-Pharmaceutical Companies and the Role of Company Size, Location, and Product Type: A Cross-Sectional Descriptive Analysis
Open the record for dataset details and reuse information.
Land use impacts on parasitic infection: A cross-sectional epidemiological study on the role of irrigated agriculture in schistosome infection in a dammed landscape
Open the record for dataset details and reuse information.
Data from: Perceptions of research bronchoscopy in Malawian adults with pulmonary tuberculosis: a cross-sectional study.
Open the record for dataset details and reuse information.
Dietary intake among urban adults with diabetes: COPEN (Colombian Nutritional Profiles), a cross-sectional study
Open the record for dataset details and reuse information.
Data from: Inaccuracy of venous point-of-care glucose measurements in critically ill patients: a cross-sectional study
Open the record for dataset details and reuse information.
Data from: Comparison of self-perceived cardiovascular disease risk among smokers with Framingham and PROCAM scores: a cross-sectional analysis of baseline data from a randomised controlled trial
Open the record for dataset details and reuse information.
Data from: Assessment of fear, anxiety, obsession and functional impairment due to COVID-19 amongst health-care workers and trainees: a cross-sectional study in Nepal
Open the record for dataset details and reuse information.
Data from: Opportunities to catalyze improved healthcare access in pluralistic systems: a cross-sectional study in Haiti
Open the record for dataset details and reuse information.
Neurology paper "Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study" Table e-1
Open the record for dataset details and reuse information.
Delays in emergency obstetrics referrals in Addis Ababa hospitals, Ethiopia: a facility-based, cross-sectional study
Open the record for dataset details and reuse information.
A cross-sectional study of nemaline myopathy supplementary figures
Open the record for dataset details and reuse information.
Five years of pharmaceutical industry funding of patient organisations in Sweden: cross-sectional study of companies, patient organisations and drugs
<p><strong>Abstract</strong></p> <p><strong>Background:</strong> Many patient organisations collaborate with drug companies, resulting in concerns about commercial agendas influencing patient advocacy. We contribute to an international body of knowledge on patient organisation-industry relations by considering payments reported in the industry’s centralised ‘collaboration database’ in Sweden. We also investigate possible commercial motives behind the funding by assessing its association with drug commercialisation. </p> <p><strong>Methods:</strong> Our primary data source were 1,337 payment reports from 2014-2018. After extraction and coding, we analysed the data descriptively, calculating the number, value and distribution of payments for various units of analysis, e.g. individual companies, diseases and payment goals. The association between drug commercialisation and patient organisation funding was assessed by, first, the concordance between leading companies marketing drugs in specific diseases and their funding of corresponding patient organisations and, second, the correlation between new drugs in broader condition areas and payments to corresponding patient organisations.</p> <p><strong>Results: </strong>46 companies reported paying €6,449.224 (median €2,411; IQR €1,024-4,569) to 77 patient organisations, but ten companies provided 67% of the funding. Small payments dominated, many of which covered costs of events organised by patient organisations. An association existed between drug commercialisation and industry funding. Companies supported patient organisations in diseases linked to their drug portfolios, with the top 3 condition areas in terms of funding – cancer endocrine, nutritional and metabolic disorders; and infectious and parasitic disorders – accounting for 63% of new drugs and 56% of the funding.</p> <p><strong>Conclusion:</strong> This study reveals close and widespread ties between patient organisations and drug companies. Relatively few companies dominated the funding landscape by supporting patient organisations in disease areas linked to their drug portfolios. This commercially motivated funding may contribute to inequalities in resource and influence between patient organisations. The association between drug commercialisation and industry funding is also worrying because of the therapeutic uncertainty of many new drugs. Our analysis benefited from the existence of a centralised database of payments – which should be adopted by other countries too – but databases should be downloadable in an analysable format to permit efficient and independent analysis.</p>
Adequate vitamin A liver stores estimated by the Modified-Relative Dose Response test are positively associated with breastfeeding but not vitamin A supplementation in Senegalese urban children 9-23 months old: a comparative cross-sectional study
<p><span><span><span><span><span><span><span><span><span><span><span>Vitamin A supplementation (VAS) in 6-59 month old children is recommended but its sustainability is currently questioned. In Senegal, data suggest that VAS should be maintained, but geographic and age-related specificities need to be addressed by gathering more evidence on the impact of this program. The objective of this comparative cross-sectional study, conducted in urban settings of Dakar, was to evaluate the effectiveness of VAS on vitamin A liver stores (VALS) among 9-23 month old children. The supplemented group (n = 119) received VAS (either 100 000 UI or 200 000 UI) 2 to 6 months before evaluation while the non-supplemented group (n = 110) had not received VAS during the past 6 months. VALS were assessed using the modified-relative dose response (MRDR) test. Serum retinol concentrations (SR) and biomarkers of subclinical inflammation were measured. Children's health-related data and feeding patterns were collected. Mean MRDR values (VAS: 0.030 ± 0.017, non-VAS: 0.028 ± 0.016, P = 0.39) and inflammation-adjusted SR (VAS: 1.34 ± 0.37, non-VAS: 1.3 ± 0.35, P = 0.51) of children were adequate. Low prevalence of VALS (VAS: 5.2%, non-VAS: 5.4%) and inflammation-adjusted VAD (VAS: 2.6%, non-VAS: 0.9%) were detected despite high presence of infections and inflammation. Children were mostly still being breastfed (VAS: 85.7%, non-VAS: 77.3%) and complementary feeding indicators were similar in both groups. Only breastfeeding was associated with VALS (adjusted OR = 0.24, 95% CI: 0.07-0.8, P = 0.02). Based on MRDR values, VAS was not related to improved VALS and SR as well as VAD reduction among these children with adequate VALS. Reinforcing breastfeeding advocacy and morbidity prevention/control are essential in this setting. Scaling-back VAS in this subpopulation should be examined regarding the risk of hypervitaminosis A. However, an evaluation of dietary VA intake sufficiency and a more quantitative assessment of VALS should be prior considered.</span></span></span></span></span></span></span></span></span></span></span></p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.